methotrexate has been researched along with Atrophy in 25 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (12.00) | 18.7374 |
| 1990's | 3 (12.00) | 18.2507 |
| 2000's | 15 (60.00) | 29.6817 |
| 2010's | 3 (12.00) | 24.3611 |
| 2020's | 1 (4.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dahlgren, D; Hellström, PM; Kullenberg, F; Lennernäs, H; Nygren, P; Peters, K; Rosenqvist, E; Sjöblom, M | 1 |
| Chhabra, A; Lam, JM; Rhemus, W | 1 |
| Al Enezi, S; Al Khalaf, MK; Al Mutairi, MA; Zakkiriah, M | 1 |
| Cavalcanti, SC; Corrêa, L; Luz, JG; Mello, SB | 1 |
| Lövblad, KO; Masterson, K; Merlini, L | 1 |
| Ates, B; Cetin, A; Otlu, A; Parlakpinar, H; Vardi, N | 1 |
| Amorós, C; Añón, R; Balza, N; Benages, A; Boscá, MM; Corts, JR; Mayordomo, E; Villagrasa, R | 1 |
| Colosimo, C; Guzzetta, F; Iuvone, L; Mariotti, P; Riccardi, R; Ruggiero, A | 1 |
| Jereb, B; Macedoni-Luksic, M; Todorovski, L | 1 |
| Abrey, LE; Correa, DD; DeAngelis, LM; Glass, A; Shi, W; Thaler, H | 1 |
| Bromberg, JE; Haaxma-Reiche, H; Harder, H; Holtel, H; Kluin-Nelemans, HC; Menten, J; Poortmans, P; van den Bent, MJ | 1 |
| Bamberg, M; Blaicher, HP; Herrlinger, U; Kanz, L; Karnath, HO; Küker, W; Uhl, M; Weller, M | 1 |
| Da Dalt, L; de Oliveira, SK; Eichenfield, LF; Galea, P; Mazur-Zielinska, H; Punaro, MG; Ros, J; Vallongo, C; Zulian, F | 1 |
| Ancona, E; Cadrobbi, R; Castagnaro, M; Cavicchioli, L; Cozzi, E; De Zan, G; Dedja, A; Hutabba, S; Ravarotto, L; Zappulli, V | 1 |
| D'Argenio, G; Di Marzo, V; Gianfrani, C; Grandone, I; Mazzarella, G; Nigam, S; Petrosino, S; Scaglione, G; Sorrentini, I; Valenti, M | 1 |
| Axon, AT; Cobden, I; Rothwell, J | 1 |
| Chu, KU; Evers, BM; Ishizuka, J; Thompson, JC; Townsend, CM | 1 |
| Chu, KU; Evers, BM; Higashide, S; Ishizuka, J; Rajaraman, S; Thompson, JC; Townsend, CM | 1 |
| Büller, HA; Dekker, J; Einerhand, AW; Meijer, HP; Renes, IB; Taminiau, JA; Verburg, M | 1 |
| Baildam, EM; Judge, MR; Ramanan, AV | 1 |
| de Guevara, CL; De-Miguel, E; Gomez-de-Segura, IA; López, JM; Ortega, M; Vázquez, I | 1 |
| Frerichs, J; Hoijer, M; Jager, D; Koetsier, M; M'Rabet, L; Meijer, HP; Smeets, RL; van't Land, B | 1 |
| Egberts, HJ; Mouwen, JM; van Dijk, JE | 1 |
| Egberts, HJ; Koninkx, JF; Mirck, MH; Mouwen, JM; Stemerdink, AF; van Dijk, JE | 1 |
| Schnitzer, A | 1 |
1 trial(s) available for methotrexate and Atrophy
| Article | Year |
|---|---|
NOA-03 trial of high-dose methotrexate in primary central nervous system lymphoma: final report.
Topics: Antimetabolites, Antineoplastic; Atrophy; Brain Neoplasms; Combined Modality Therapy; Humans; Lymphoma; Magnetic Resonance Imaging; Methotrexate; Middle Aged; Quality of Life; Treatment Outcome | 2005 |
24 other study(ies) available for methotrexate and Atrophy
| Article | Year |
|---|---|
Evaluation and validation of chemotherapy-specific diarrhoea and histopathology in rats.
Topics: Animals; Antineoplastic Agents; Atrophy; Body Weight; Diarrhea; Doxorubicin; Fluorouracil; Idarubicin; Intestinal Mucosa; Irinotecan; Male; Methotrexate; Mucositis; Rats; Rats, Wistar | 2022 |
Tongue Involvement in Parry-Romberg Syndrome.
Topics: Adolescent; Atrophy; Child, Preschool; Disease Progression; Facial Hemiatrophy; Female; Glucocorticoids; Humans; Methotrexate; Prednisone; Tongue | 2017 |
Parry-Romberg syndrome in Kuwait. Neurological manifestations in 2 children.
Topics: Adolescent; Anticonvulsants; Atrophy; Cerebrum; Child; Electroencephalography; Epilepsies, Partial; Facial Hemiatrophy; Female; Glucocorticoids; Humans; Immunosuppressive Agents; Ischemic Attack, Transient; Kuwait; Magnetic Resonance Imaging; Male; Methotrexate; Prednisolone | 2019 |
The effect of methotrexate on the bone healing of mandibular condylar process fracture: an experimental study in rats.
Topics: Alkaline Phosphatase; Animals; Atrophy; Bone Remodeling; Bone Resorption; Bony Callus; Cartilage, Articular; Connective Tissue; Disease Models, Animal; Fibrocartilage; Fracture Healing; Immunosuppressive Agents; Injections, Intraperitoneal; Male; Mandibular Condyle; Mandibular Fractures; Methotrexate; Osteogenesis; Random Allocation; Rats; Rats, Wistar; Temporomandibular Joint; Tissue Survival | 2014 |
Coexistence of reversible cerebral neurotoxicity and irreversible cerebellar atrophy following an intrathecal methotrexate chemotherapy: two case reports.
Topics: Adolescent; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Atrophy; Brain; Cerebellum; Child; Female; Humans; Injections, Spinal; Leukemia, B-Cell; Lymphoma; Magnetic Resonance Imaging; Male; Methotrexate | 2009 |
Antiapoptotic and antioxidant effects of beta-carotene against methotrexate-induced testicular injury.
Topics: Animals; Antimetabolites, Antineoplastic; Antioxidants; Apoptosis; Atrophy; beta Carotene; Caspase 3; Cytoprotection; Drug Interactions; Male; Methotrexate; Oxidative Stress; Rats; Rats, Wistar; Testis | 2009 |
Methotrexate induced sprue-like syndrome.
Topics: Antirheumatic Agents; Atrophy; Biopsy; Celiac Disease; Duodenum; Endoscopy, Gastrointestinal; Humans; Male; Methotrexate; Middle Aged; Spondylitis, Ankylosing; Syndrome | 2008 |
Long-term cognitive outcome, brain computed tomography scan, and magnetic resonance imaging in children cured for acute lymphoblastic leukemia.
Topics: Antibiotic Prophylaxis; Antimetabolites, Antineoplastic; Atrophy; Brain; Brain Neoplasms; Child; Child, Preschool; Cognition Disorders; Female; Follow-Up Studies; Humans; Infant; Infusions, Intravenous; Intelligence Tests; Magnetic Resonance Imaging; Male; Methotrexate; Neuropsychological Tests; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Radiation Injuries; Radiotherapy, Adjuvant; Survival Rate; Tomography, X-Ray Computed | 2002 |
Long-term sequelae in children treated for brain tumors: impairments, disability, and handicap.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Atrophy; Brain; Brain Damage, Chronic; Brain Neoplasms; Calcinosis; Child; Child, Preschool; Cisplatin; Combined Modality Therapy; Cranial Irradiation; Cyclophosphamide; Disabled Children; Epilepsy; Etoposide; Female; Humans; Hydrocephalus; Infant; Intellectual Disability; Learning Disabilities; Lomustine; Magnetic Resonance Imaging; Male; Methotrexate; Movement Disorders; Neoplasm Recurrence, Local; Prevalence; Procarbazine; Radiation Injuries; Slovenia; Survivors; Tomography, X-Ray Computed; Unemployment; Vincristine; Vision Disorders | 2003 |
Cognitive functions in survivors of primary central nervous system lymphoma.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Atrophy; Attention; Brain; Central Nervous System Neoplasms; Cognition Disorders; Cohort Studies; Combined Modality Therapy; Cranial Irradiation; Female; Humans; Injections, Spinal; Lymphoma, Non-Hodgkin; Magnetic Resonance Imaging; Male; Memory; Methotrexate; Middle Aged; Myelin Sheath; Neuropsychological Tests; Prospective Studies; Quality of Life; Remission Induction; Survivors | 2004 |
Cognitive status and quality of life after treatment for primary CNS lymphoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Atrophy; Brain; Carmustine; Case-Control Studies; Central Nervous System Neoplasms; Cognition Disorders; Cohort Studies; Combined Modality Therapy; Cranial Irradiation; Cytarabine; Female; Humans; Hydrocortisone; Injections, Spinal; Lymphoma, Non-Hodgkin; Male; Methotrexate; Methylprednisolone; Middle Aged; Myelin Sheath; Neuropsychological Tests; Prospective Studies; Quality of Life; Teniposide | 2004 |
Congenital localized scleroderma.
Topics: Atrophy; Biopsy; Chelating Agents; Child, Preschool; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Infant; Infant, Newborn; Methotrexate; Penicillamine; Scleroderma, Localized; Skin | 2006 |
Histopathological findings in the gastrointestinal tract of primate recipients of porcine renal xenografts following different immunosuppressive regimens.
Topics: Animals; Atrophy; CD55 Antigens; Cyclophosphamide; Female; Gastrointestinal Tract; Graft Rejection; Immunosuppressive Agents; Inflammation; Kidney; Kidney Transplantation; Macaca fascicularis; Methotrexate; Swine; Transplantation, Heterologous | 2007 |
Overactivity of the intestinal endocannabinoid system in celiac disease and in methotrexate-treated rats.
Topics: Adolescent; Adult; Amides; Animals; Arachidonic Acids; Atrophy; Cannabinoid Receptor Modulators; Case-Control Studies; Celiac Disease; Child; Diet, Protein-Restricted; Disease Models, Animal; Duodenum; Endocannabinoids; Ethanolamines; Female; Glycerides; Humans; Jejunum; Male; Methotrexate; Middle Aged; Palmitic Acids; Peroxidase; Polyunsaturated Alkamides; Rats; Rats, Wistar; Receptor, Cannabinoid, CB1; Time Factors; Up-Regulation | 2007 |
Passive permeability in experimental intestinal damage in rats.
Topics: Animals; Atrophy; Cetrimonium; Cetrimonium Compounds; Intestinal Absorption; Intestinal Mucosa; Lactulose; Male; Mannitol; Methotrexate; Rats | 1981 |
Role of bombesin on gut mucosal growth.
Topics: Animals; Atrophy; Bombesin; Diet; Intestinal Diseases; Intestinal Mucosa; Male; Methotrexate; Rats; Rats, Inbred F344 | 1995 |
Bombesin improves survival from methotrexate-induced enterocolitis.
Topics: Animals; Atrophy; Bombesin; Enterocolitis; Food Additives; Food, Formulated; Ileal Diseases; Intestinal Mucosa; Male; Methotrexate; Organic Chemicals; Rats; Rats, Inbred F344 | 1994 |
Selective sparing of goblet cells and paneth cells in the intestine of methotrexate-treated rats.
Topics: Animals; Antimetabolites, Antineoplastic; Apoptosis; Atrophy; Biomarkers; Cell Count; Cell Differentiation; Gene Expression; Goblet Cells; In Situ Nick-End Labeling; Intestinal Neoplasms; Intestines; Male; Methotrexate; Mucin-2; Mucins; Muscle Proteins; Paneth Cells; Peptides; Proteins; Rats; Rats, Inbred Strains; Regeneration; RNA, Messenger; Trefoil Factor-3 | 2000 |
Atrophoderma and juvenile idiopathic arthritis.
Topics: Adolescent; Antirheumatic Agents; Arthritis, Juvenile; Atrophy; Female; Humans; Methotrexate; Skin | 2001 |
Effects of growth hormone plus a hyperproteic diet on methotrexate-induced injury in rat intestines.
Topics: Animals; Apoptosis; Atrophy; Bacterial Translocation; Body Weight; Cell Division; Dietary Proteins; Drug Evaluation; Human Growth Hormone; Insulin-Like Growth Factor I; Intestinal Diseases; Intestinal Mucosa; Ki-67 Antigen; Malabsorption Syndromes; Male; Methotrexate; Rats; Rats, Wistar; Recombinant Proteins; Somatostatin; Somatostatin-28 | 2001 |
Transforming Growth Factor-beta2 protects the small intestine during methotrexate treatment in rats possibly by reducing stem cell cycling.
Topics: Administration, Oral; Animals; Antimetabolites, Antineoplastic; Atrophy; Cell Cycle; Cell Death; Disease Models, Animal; Epithelial Cells; Female; Immunosuppressive Agents; Intestine, Small; Methotrexate; Rats; Transforming Growth Factor beta; Transforming Growth Factor beta2; Weight Loss | 2002 |
Thickening of the glycocalyx during methotrexate induced small intestinal mucosal atrophy in the rat.
Topics: Animals; Atrophy; Glycoproteins; Intestinal Mucosa; Jejunum; Male; Methotrexate; Polysaccharides; Rats; Rats, Inbred Strains | 1992 |
Histochemical changes in the composition of mucins in goblet cells during methotrexate-induced mucosal atrophy in rats.
Topics: Animals; Atrophy; Body Weight; Eating; Epithelium; Female; Intestinal Mucosa; Jejunum; Methotrexate; Mitosis; Mucins; Rats; Sialomucins; Time Factors | 1988 |
On methotrexate treatment of psoriasis. Model of a cytostatics treatment.
Topics: Age Factors; Alopecia; Atrophy; Carcinoma, Basal Cell; Diarrhea; Gastritis; Gastrointestinal Hemorrhage; Gingival Diseases; Gingivitis, Necrotizing Ulcerative; Humans; Immunologic Deficiency Syndromes; Immunosuppression Therapy; Infections; Inflammation; Methotrexate; Nausea; Psoriasis; Skin Neoplasms; Stomatitis, Aphthous | 1972 |